Susan C. Stewart, M.D.

Dr. Stewart reports no commercial conflict of interest.

Release Date: 07/22/1998
Termination Date: 07/22/2001

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Discuss the major menopausal changes as a guide for a treatment intervention during that time of life
• Recommend a program of intervention based on a thorough understanding by patient of her risks and benefits
• Discuss two new intervention medications, alendronate and raloxifene.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity